Additionally, There was a one-time gain on the sale of some self-developed properties of $22 million, which approximately offset the pull forward of the ballot initiative spend. The increase in G&A relative to Q1 was largely the result of higher compensation expense and the increased T&E.
Aug 1, 2022 / receipt, needs a key / Joel Ackerman, CFO | earnings call 2022-08-01 | transcript b42cd7c6-5b7f-4675-b89a-65311c625c49 | chars 11601-11890 | segment 11
So just to put a finger on something that we are all experiencing is travel and entertainment. which we, of course, at one quarter over another, you could say we used to have a run rate. Has the world actually changed in travel and entertainment? It's going to be completely different.
Feb 10, 2022 / receipt, needs a key / CEO, CEO | earnings call 2022-02-10 | transcript e0ee7a45-4adb-436b-912d-0eeb13d41bc8 | chars 22146-22431 | segment 22
Our Q2 results include a net COVID headwind of approximately $35 million, similar to what we saw in Q1. primarily the impact of excess mortality on volume and elevated PPE costs, partially offset by sequestration relief and reduced travel and meeting expenses.
Aug 3, 2021 / receipt, needs a key / Joel Ackerman, CFO | earnings call 2021-08-03 | transcript 5e4fe899-8f54-436f-a804-7b2029b35721 | chars 10308-10568 | segment 10
And then looking towards the back half of the year, we've taken down some of the COVID offsets that we were expecting from G&A and T&E.
Apr 29, 2021 / receipt, needs a key / Joel, other | earnings call 2021-04-29 | transcript a90299f5-992f-4b3e-90e3-4326629c493b | chars 14195-14330 | segment 14
This is the result of lower COVID impact in Q1 the recently passed extension of the Medicare sequestration relief through the end of the year, and lower other offsets including T&E in the back half of the year.
Apr 29, 2021 / receipt, needs a key / Joel Ackerman, CFO | earnings call 2021-04-29 | transcript a90299f5-992f-4b3e-90e3-4326629c493b | chars 10897-11107 | segment 11
No, think of, you know, our T&E is down, and it's been down since the beginning of COVID as teammates travel less, and we had modeled that continuing through the end of the year, and now we think, for example, that T&E in Q3 and Q4 could return closer to pre-COVID levels.
Apr 29, 2021 / receipt, needs a key / Joel, other | earnings call 2021-04-29 | transcript a90299f5-992f-4b3e-90e3-4326629c493b | chars 19345-19617 | segment 20
Through the first three quarters of the year, the net COVID impact was reduced as the increased costs associated with COVID were offset by lower benefits, travel, and G&A spend.
Feb 11, 2021 / receipt, needs a key / Javier Rodriguez, CEO | earnings call 2021-02-11 | transcript 6463c97d-0237-445e-9847-7b4a42285bd7 | chars 5732-5909 | segment 6
Bucket two are the offsets, lower T&E, the Medicare sequestration revenue, lower benefits as a self-insured employer.
Feb 11, 2021 / receipt, needs a key / Joel, CEO | earnings call 2021-02-11 | transcript 6463c97d-0237-445e-9847-7b4a42285bd7 | chars 16199-16316 | segment 16
We think T&E will remain low, but the health benefits associated with teammates will come down.
Feb 11, 2021 / receipt, needs a key / Joel, CEO | earnings call 2021-02-11 | transcript 6463c97d-0237-445e-9847-7b4a42285bd7 | chars 17265-17360 | segment 18
And then T&E is a question mark.
Oct 29, 2020 / receipt, needs a key / Eric, other | earnings call 2020-10-29 | transcript f0a9c595-ce23-49ca-918e-233bb150fb66 | chars 20280-20312 | segment 21
The ones I'd call out most are the sequestration, suspension, lower T&E, lower benefit costs, and the direct costs that we saw in Q2 largely went away, not completely went away, but to a large extent went away.
Oct 29, 2020 / receipt, needs a key / Lisa, CFO | earnings call 2020-10-29 | transcript f0a9c595-ce23-49ca-918e-233bb150fb66 | chars 26997-27207 | segment 28
Our strong operational performance came despite investments and expenses we incurred in response to COVID. offset by savings associated with COVID in the form of reduced travel and health benefit expenses, among other items, which Joel will explain in more detail.
Jul 30, 2020 / receipt, needs a key / Javier Rodriguez, CEO | earnings call 2020-07-30 | transcript 14a00eec-4378-4756-a300-fe138d04e1a7 | chars 3831-4095 | segment 3
Pflegefachkraft (m/w/d) | {"ats": "workday", "city": null, "state": null, "job_id": "/job/07635---Alsdorf/Pflegefachkraft--m-w-d-_R0468899", "remote": false, "category": "other", "function": "other",
company_statement / Sep 15, 2026 / receipt
Reinigungskraft (m/w/d) - Minijob | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Aachen/Reinigungskraft--m-w-d----Minijob_R0458544", "remote": false, "category": "other", "function"
company_statement / Sep 15, 2026 / receipt
Facharzt/Fachärztin für Allgemeinmedizin (m/w/d) | {"ats": "workday", "city": null, "state": null, "job_id": "/job/07299---Essen/Facharzt-Fachrztin-fr-Allgemeinmedizin--m-w-d-_R0474675-2", "remote": f
company_statement / Aug 25, 2026 / receipt
Facharzt Innere Medizin und Nephrologie - Ärztliche Leitung (m/w/d) - Essen | {"ats": "workday", "city": null, "state": null, "job_id": "/job/07299---Essen/rztliche-Leitung---Nephrologie--m-w-d-_R0465
company_statement / Aug 25, 2026 / receipt
Facharzt Allgemeinmedizin / Innere Medizin (m/w/d) - Hausärztliche Versorgung | {"ats": "workday", "city": null, "state": null, "job_id": "/job/07380---Rheydt/Facharzt-Allgemeinmedizin---Innere-Medizi
company_statement / Aug 25, 2026 / receipt
Facharzt Innere Medizin und Nephrologie (m/w/d) - Ahrweiler | {"ats": "workday", "city": null, "state": null, "job_id": "/job/07475---Ahrweiler/Facharzt-fr-Innere-Medizin---Nephrologie--m-w-d-_R045575
company_statement / Aug 25, 2026 / receipt
Facharzt Innere Medizin und Nephrologie - Ärztliche Leitung (m/w/d) - Falkensee | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Falkensee/rztliche-Leitung---Nephrologie--m-w-d-_R0439
company_statement / Aug 25, 2026 / receipt
Medizinische Fachangestellte / MFA (m/w/d) | {"ats": "workday", "city": null, "state": null, "job_id": "/job/07298---Emden/Medizinischer-Fachangestellter---MFA--m-w-d----Praxis_R0467677", "remote": fa
company_statement / Aug 24, 2026 / receipt
Medizinische Fachangestellte / MFA (m/w/d) - Dormagen | {"ats": "workday", "city": null, "state": null, "job_id": "/job/07365---Dormagen/Medizinischer-Fachangestellter---MFA--m-w-d----Praxis_R0447940"
company_statement / Aug 24, 2026 / receipt
Medizinische Fachangestellte / MFA (m/w/d) | {"ats": "workday", "city": null, "state": null, "job_id": "/job/07634---Falkensee/Medizinischer-Fachangestellter---MFA--m-w-d----Praxis_R0466494-1", "remot
company_statement / Aug 24, 2026 / receipt
Facharzt Allgemeinmedizin - Hausärztliche Versorgung (m/w/d) - Neuss | {"ats": "workday", "city": null, "state": null, "job_id": "/job/07352---Neuss/Facharzt-Allgemeinmedizin---Hausrztliche-Versorgung
company_statement / Aug 10, 2026 / receipt
IT-Projektmanager Infrastruktur & Cloud Transformation (m/w/d) | {"ats": "workday", "city": null, "state": null, "job_id": "/job/07116----Hamburg/IT-Projektmanager-in-Cloud-Migration---Automatisierung
company_statement / Aug 6, 2026 / receipt
| Javier Rodriguez | CEO | - | receipt |
| Joel Ackerman | CFO | receipt |
| 2026-11-04 | earnings call | scheduled | ir |
| 2019-04-29 | Chief Executive Officer, appointed | sec_8k |